Literature DB >> 15262195

Effectiveness of HMG-CoA reductase inhibitors is modified by the ACE insertion deletion polymorphism.

Anke-Hilse Maitland-van der Zee, Olaf H Klungel, Hubertus G M Leufkens, Anthonius de Boer, Bruno H Ch Stricker, Albert Hofman, Jacqueline C M Witteman, Cornelia M van Duijn, John J P Kastelein.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15262195     DOI： 10.1016/j.atherosclerosis.2004.04.009

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  6 in total

Review 1.  Pharmacogenetics of response to statins: where do we stand?

Authors:  Anke-Hilse Maitland-van der Zee; Eric Boerwinkle
Journal:  Curr Atheroscler Rep       Date:  2005-05       Impact factor: 5.113

2.  Absence of an interaction between the angiotensin-converting enzyme insertion-deletion polymorphism and pravastatin on cardiovascular disease in high-risk hypertensive patients: the Genetics of Hypertension-Associated Treatment (GenHAT) study.

Authors:  Anke-Hilse Maitland-van der Zee; Eric Boerwinkle; Donna K Arnett; Barry R Davis; Catherine Leiendecker-Foster; Michael B Miller; Olaf H Klungel; Charles E Ford; John H Eckfeldt
Journal:  Am Heart J       Date:  2007-01       Impact factor: 4.749

3.  Pharmacogenetics of cardiovascular drug therapy.

Authors:  Bas J M Peters; Olaf H Klungel; Anthonius de Boer; Bruno H Ch Stricker; Anke-Hilse Maitland-van der Zee
Journal:  Clin Cases Miner Bone Metab       Date:  2009-01

Review 4.  Review of the cost effectiveness of pharmacogenetic-guided treatment of hypercholesterolaemia.

Authors:  Michael J Sorich; Michael D Wiese; Rebekah L O'Shea; Brita Pekarsky
Journal:  Pharmacoeconomics       Date:  2013-05       Impact factor: 4.981

5.  ACE (I/D) polymorphism and response to treatment in coronary artery disease: a comprehensive database and meta-analysis involving study quality evaluation.

Authors:  Georgios Kitsios; Elias Zintzaras
Journal:  BMC Med Genet       Date:  2009-06-04       Impact factor: 2.103

6.  ACE genotype, risk and causal relationship to stroke: implications for treatment.

Authors:  Agnieszka Slowik; Tomasz Dziedzic; Joanna Pera; Dorota Wloch; Grzegorz Kopec; Andrzej Szczudlik
Journal:  Curr Treat Options Cardiovasc Med       Date:  2007-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.